Acorda Therapeutics Inc (ACORQ)
0.85
+0.15
(+21.43%)
USD |
OTCM |
May 21, 15:50
Acorda Therapeutics Shareholders Equity (Quarterly): -185.77M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -185.77M |
December 31, 2023 | -157.96M |
September 30, 2023 | 58.96M |
June 30, 2023 | 67.87M |
March 31, 2023 | 76.96M |
December 31, 2022 | 93.62M |
September 30, 2022 | 75.77M |
June 30, 2022 | 87.91M |
March 31, 2022 | 127.55M |
December 31, 2021 | 151.14M |
September 30, 2021 | 164.48M |
June 30, 2021 | 190.48M |
March 31, 2021 | 206.28M |
December 31, 2020 | 237.96M |
September 30, 2020 | 313.53M |
June 30, 2020 | 290.90M |
March 31, 2020 | 306.67M |
December 31, 2019 | 310.82M |
September 30, 2019 | 281.34M |
June 30, 2019 | 544.84M |
March 31, 2019 | 566.59M |
December 31, 2018 | 611.98M |
September 30, 2018 | 598.62M |
June 30, 2018 | 606.64M |
March 31, 2018 | 549.92M |
Date | Value |
---|---|
December 31, 2017 | 519.99M |
September 30, 2017 | 679.99M |
June 30, 2017 | 689.72M |
March 31, 2017 | 676.13M |
December 31, 2016 | 664.21M |
September 30, 2016 | 666.77M |
June 30, 2016 | 671.64M |
March 31, 2016 | 684.01M |
December 31, 2015 | 603.02M |
September 30, 2015 | 574.89M |
June 30, 2015 | 560.28M |
March 31, 2015 | 549.02M |
December 31, 2014 | 540.26M |
September 30, 2014 | 522.91M |
June 30, 2014 | 500.38M |
March 31, 2014 | 450.52M |
December 31, 2013 | 440.35M |
September 30, 2013 | 426.39M |
June 30, 2013 | 404.80M |
March 31, 2013 | 391.64M |
December 31, 2012 | 385.92M |
September 30, 2012 | 245.47M |
June 30, 2012 | 229.65M |
March 31, 2012 | 219.09M |
December 31, 2011 | 205.21M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-185.77M
Minimum
Mar 2024
544.84M
Maximum
Jun 2019
162.17M
Average
157.81M
Median
Shareholders Equity (Quarterly) Benchmarks
BioSig Technologies Inc | -2.913M |
Verve Therapeutics Inc | 583.07M |
Spectral AI Inc | 1.456M |
AIM ImmunoTech Inc | 4.826M |
Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 81.58M |
Total Liabilities (Quarterly) | 267.35M |
Debt to Equity Ratio | -1.031 |
Current Ratio | 0.2164 |
Net Debt Paydown Yield | -29.79% |